-+ 0.00%
-+ 0.00%
-+ 0.00%

CLEARMIND MEDICINE ANNOUNCES SUCCESSFUL COMPLETION OF SECOND COHORT ENROLLMENT IN ONGOING FDA-APPROVED PHASE I/IIA TRIAL FOR CMND-100

Reuters·12/16/2025 13:45:00

Please log in to view news